8-hydroxyguanine and Cognition-Disorders

8-hydroxyguanine has been researched along with Cognition-Disorders* in 2 studies

Other Studies

2 other study(ies) available for 8-hydroxyguanine and Cognition-Disorders

ArticleYear
HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer's disease.
    Nature communications, 2020, 05-18, Volume: 11, Issue:1

    DNA damage contributes to brain aging and neurodegenerative diseases. However, the factors stimulating DNA repair to stave off functional decline remain obscure. We show that HDAC1 modulates OGG1-initated 8-oxoguanine (8-oxoG) repair in the brain. HDAC1-deficient mice display age-associated DNA damage accumulation and cognitive impairment. HDAC1 stimulates OGG1, a DNA glycosylase known to remove 8-oxoG lesions that are associated with transcriptional repression. HDAC1 deficiency causes impaired OGG1 activity, 8-oxoG accumulation at the promoters of genes critical for brain function, and transcriptional repression. Moreover, we observe elevated 8-oxoG along with reduced HDAC1 activity and downregulation of a similar gene set in the 5XFAD mouse model of Alzheimer's disease. Notably, pharmacological activation of HDAC1 alleviates the deleterious effects of 8-oxoG in aged wild-type and 5XFAD mice. Our work uncovers important roles for HDAC1 in 8-oxoG repair and highlights the therapeutic potential of HDAC1 activation to counter functional decline in brain aging and neurodegeneration.

    Topics: Acetylation; Aging; Alzheimer Disease; Animals; Astrocytes; Base Sequence; Benzophenones; Brain; Cognition; Cognition Disorders; DNA Damage; DNA Glycosylases; Down-Regulation; Gene Ontology; Guanine; Histone Deacetylase 1; Memory; Mice, Inbred C57BL; Mice, Knockout; Neurons; Oxidative Stress; Promoter Regions, Genetic

2020
Oxidatively modified RNA in mild cognitive impairment.
    Neurobiology of disease, 2008, Volume: 29, Issue:2

    Studies show increased oxidative damage in the brains of subjects with Alzheimer's disease (AD) and mild cognitive impairment (MCI). To determine if RNA oxidation occurs in MCI, sections of hippocampus/parahippocampal gyrus (HPG) from 5 MCI, 5 late stage AD (LAD) and 5 age-matched normal control (NC) subjects were subjected to immunohistochemistry using antibodies against 8-hydroxyguanine (8-OHG) and 1-N2-propanodeoxyguanosine (NPrG). Confocal microscopy showed 8-OHG and NPrG immunostaining was significantly (p<0.05) elevated in MCI and LAD HPG compared with NC subjects and was predominately associated with neurons identified using the MC-1 antibody that recognizes conformational alterations of tau, which are associated with early neurofibrillary tangle formation. Pretreating sections with RNase or DNase-I showed immunostaining for both adducts was primarily associated with RNA. In addition, levels of both adducts in MCI were comparable to those measured in LAD, suggesting RNA oxidation may be an early event in the pathogenesis of neuron degeneration in AD.

    Topics: Adenosine Triphosphatases; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brain; Cation Transport Proteins; Cognition Disorders; Copper-Transporting ATPases; Deoxyguanosine; Female; Guanine; Humans; Male; Microscopy, Confocal; Oxidation-Reduction; Oxidative Stress; Postmortem Changes; RNA; Statistics, Nonparametric

2008